| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 27 |
| 1 | TREPROSTINIL | 24 |
| 2 | SILDENAFIL | 20 |
| 3 | SILDENAFIL POWDER, | 18 |
| 4 | AMBRISENTAN | 17 |
| 5 | MACITENTAN | 16 |
| 6 | BOSENTAN | 13 |
| 7 | TADALAFIL | 13 |
| 8 | RIOCIGUAT | 11 |
| 9 | METHYLENE BLUE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM THIOSULFATE | 3 | 0.0054 |
| 1 | METHYLENE BLUE | 8 | 0.0051 |
| 2 | ILOPROST | 3 | 0.0032 |
| 3 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 4 | IBUPROFEN LYSINE | 1 | 0.0018 |
| 5 | GLYCOPYRRONIUM | 1 | 0.0006 |
| 6 | MANNITOL | 3 | 0.0006 |
| 7 | SILDENAFIL POWDER, | 18 | 0.0005 |
| 8 | HYPROMELLOSE | 1 | 0.0004 |
| 9 | RIOCIGUAT | 11 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 3 | 0.0032 |
| 1 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 2 | Soluble Guanylate Cyclase Stimulator [EPC] | 11 | 0.0003 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 29 | 0.0002 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 5 | 0.0002 |
| 5 | Prostacycline Vasodilator [EPC] | 25 | 0.0002 |
| 6 | Endothelin Receptor Antagonist [EPC] | 31 | 0.0002 |
| 7 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | General Anesthetic [EPC] | 4 | 0.0001 |